Gilead Sciences
GILD
1,493 hedge funds and large institutions have $121B invested in Gilead Sciences in 2015 Q1 according to their latest regulatory filings, with 153 funds opening new positions, 655 increasing their positions, 554 reducing their positions, and 83 closing their positions.
84% more first-time investments, than exits
New positions opened: 153 | Existing positions closed: 83
18% more repeat investments, than reductions
Existing positions increased: 655 | Existing positions reduced: 554
4% more funds holding
Funds holding: 1,439 → 1,493 (+54)
1% more capital invested
Capital invested by funds: $120B → $121B (+$1.13B)
8% less funds holding in top 10
Funds holding in top 10: 196 → 180 (-16)
33% less call options, than puts
Call options by funds: $2.47B | Put options by funds: $3.71B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$316M |
| 2 |
Renaissance Technologies
New York
|
+$314M |
| 3 |
Bank of New York Mellon
New York
|
+$299M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$274M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$217M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Americafirst Capital Management
Roseville,
California
|
-$1.2B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$483M |
| 3 |
MCM
Marsico Capital Management
Denver,
Colorado
|
-$346M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$285M |
| 5 |
JP Morgan Chase
New York
|
-$274M |
GILD Hedge Fund Activity: Q1 2015 in Review
1,493 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q1 2015, worth a combined $121B — up 0.94% from $120B a quarter earlier.
Buyers outnumbered sellers: 153 funds opened new GILD positions and 83 closed out — a net gain of 70 holders — while 655 added to existing stakes and 554 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $316M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $1.2B sold.
- 1,493 institutional investors held Gilead Sciences (GILD) as of Q1 2015, up from 1,439 in Q4 2014.
- Funds reported $121B of Gilead Sciences stock for Q1 2015, up 0.94% quarter-over-quarter.
- 153 funds opened new Gilead Sciences positions in Q1 2015 and 83 closed out, a net change of +70 holders.
- The largest Gilead Sciences buyer in Q1 2015 was Capital Research Global Investors, an estimated $316M added.
- The largest Gilead Sciences seller in Q1 2015 was Americafirst Capital Management, an estimated $1.2B sold.
Based on aggregated 13F filings for Q1 2015.